SwanBio Therapeutics Appoints Steven Zelenkofske, DO, as Chief Medical Officer

BALA CYNWYD, Pa., June 1, 2020 -- (Healthcare Sales & Marketing Network) -- SwanBio Therapeutics, a gene therapy company developing leading-edge medicines to deliver dramatic clinical efficacy for the treatment of adrenomyeloneuropathy (AMN) and other neu... Biopharmaceuticals, Neurology, Personnel SwanBio Therapeutics, adeno-associated virus, adrenomyeloneuropathy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news